Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

REAGENT SET, ANTIBOD

Active
SPE2DS-26-T-148QFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the procurement of a reagent set for antibodies, identified by NSN/Part Number 6550-01-204-5368, with a quantity of one unit requested under purchase request number 7017121423. The solicitation, labeled SPE2DS-26-T-148Q, was posted by the Defense Logistics Agency of the Department of Defense on June 11, 2026, with responses due by June 17, 2026. This contract is a federal solicitation intended for suppliers to provide the specified reagent set, but does not indicate any set-aside type or specify the size or type of business preferred for submission. The contract details include limited information about the place of performance or specific office address, implying that these details may be provided upon award or through direct inquiry. The solicitation is managed by the Defense Logistics Agency, responsible for supplying materials across the Department of Defense. Interested parties can access the complete solicitation documents and respond via the provided DLA Bid System electronic portal, facilitating a competitive procurement process for this specialized reagent set.

General Info

Procurement of one antibody reagent set, solicitation by Defense Logistics Agency, responses due June 17, 2026.

Agency

Department Of Defense → Defense Logistics Agency

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing View NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUS
Organization / Agency
Department Of Defense → Defense Logistics Agency
Office AddressUS
ContactsNo contact information available

Full Description

Show more
REAGENT SET, ANTIBOD NSN/Part Number: 6550-01-204-5368 Purchase Request: 7017121423QTY: 1

Similar Contracts

NAICS: 325413
New
Federal
Service-Disabled Veteran-owned Small Business (SDVOSB) certified vendor of Terumo-brand blood collection productsThe Defense Health Agency is conducting a sources sought notice to identify qualified Service-Disabled Veteran-Owned Small Business (SDVOSB) vendors capable of supplying specific Terumo-brand blood collection products. This announcement is strictly for market research purposes and does not constitute a solicitation or a promise to award a contract. Interested parties are required to submit detailed written responses demonstrating their technical expertise, including company information, business certifications, and proof of veteran-owned small business status via the SBA VetCert system. The targeted products include Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD wafers, ACD-A Solution 750ml bags, and a 150 mL item with a coupler. Responses must be emailed by 5:00 pm EDT on June 18, 2026, to the designated point of contact at the Defense Health Agency, located at Fort Detrick, Maryland. Participation in this sources sought does not guarantee solicitation issuance or contract award, and no reimbursement will be provided for costs incurred in responding. Businesses must also be registered in the System for Award Management (SAM) and comply with associated certifications. The acquisition falls under NAICS code 325413 with a size standard of 1,250 employees, focusing on in vitro diagnostic substance manufacturing, with no anticipated subcontracting opportunities. The location for performance is in Texas.
Defense Health Agency

POSTED

about 21 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325413
New
Federal
NOI -Illumina Infinium Methylation Screening ArrayThe National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a non-competitive combined synopsis/solicitation (number 75N98026Q00600) for the procurement of twenty Infinium Methylation Screening Array-48 Kits from Illumina, Inc. This firm-fixed-price purchase order will support the NHLBI Division of Intramural Research, specifically the Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LoGICO). Illumina is the sole manufacturer of this proprietary BeadChip product, which is protected by patents and trade secrets, and is uniquely compatible with the existing Illumina iScan System and Infinium Automated Pipetting System installed at the NIA Laboratory of Neurogenetics. No other vendor offers a functionally equivalent product, and Illumina has confirmed it has not authorized any intermediaries to supply this item. The acquisition is conducted under the streamlined solicitation authority for commercial items as specified in FAR Subpart 12.6 and FAR 12.603, and it does not exceed the simplified acquisition threshold. It is not set aside for small businesses, falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing, with a size standard of 1,250 employees. The solicitation incorporates clauses effective through the Federal Acquisition Circular 2026-01. Responses are due by June 18, 2026, and the point of contact for this procurement is Nicholas S. Capobianco of NIH.
National Institutes Of Health Olao

POSTED

about 21 hours ago

DEADLINE

in 7 days
View Details